217 related articles for article (PubMed ID: 22228316)
1. Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications.
Crews MP; Howes OD
Hum Psychopharmacol; 2012 Jan; 27(1):15-23. PubMed ID: 22228316
[TBL] [Abstract][Full Text] [Related]
2. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.
De Hert M; Detraux J; Stubbs B
Expert Opin Drug Saf; 2016 Jun; 15(6):809-23. PubMed ID: 26986209
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis in patients with schizophrenia.
Hummer M; Malik P; Gasser RW; Hofer A; Kemmler G; Moncayo Naveda RC; Rettenbacher MA; Fleischhacker WW
Am J Psychiatry; 2005 Jan; 162(1):162-7. PubMed ID: 15625215
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic-induced hyperprolactinaemia in patients with schizophrenia: considerations in relation to bone mineral density.
Stubbs B
J Psychiatr Ment Health Nurs; 2009 Nov; 16(9):838-42. PubMed ID: 19824978
[TBL] [Abstract][Full Text] [Related]
5. Gender-specific risk factors for low bone mineral density in patients taking antipsychotics for psychosis.
Jhon M; Yoo T; Lee JY; Kim SY; Kim JM; Shin IS; Williams L; Berk M; Yoon JS; Kim SW
Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29315805
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in male schizophrenia patients: a review.
Meyer JM; Lehman D
Ann Clin Psychiatry; 2006; 18(1):43-8. PubMed ID: 16517452
[TBL] [Abstract][Full Text] [Related]
7. Risk of osteoporosis and fracture incidence in patients on antipsychotic medication.
Graham SM; Howgate D; Anderson W; Howes C; Heliotis M; Mantalaris A; Tsiridis E; Tsapakis E
Expert Opin Drug Saf; 2011 Jul; 10(4):575-602. PubMed ID: 21385106
[TBL] [Abstract][Full Text] [Related]
8. [Decrease in mineral bone density in schizophrenic patients treated with 2nd generation antipsychotics].
Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
Psychiatr Pol; 2005; 39(6):1173-84. PubMed ID: 16526183
[TBL] [Abstract][Full Text] [Related]
9. [Osteoporosis risk factors among patients with schizophrenia].
Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
Przegl Lek; 2006; 63(3):134-8. PubMed ID: 16969898
[TBL] [Abstract][Full Text] [Related]
10. Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study.
Wang M; Hou R; Jian J; Mi G; Qiu H; Cao B; Tang M
Hum Psychopharmacol; 2014 Mar; 29(2):183-9. PubMed ID: 24738111
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia.
Meaney AM; Smith S; Howes OD; O'Brien M; Murray RM; O'Keane V
Br J Psychiatry; 2004 Jun; 184():503-8. PubMed ID: 15172944
[TBL] [Abstract][Full Text] [Related]
12. Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics.
Liu-Seifert H; Kinon BJ; Ahl J; Lamberson S
Ann N Y Acad Sci; 2004 Dec; 1032():297-8. PubMed ID: 15677434
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
Haddad PM; Wieck A
Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
[TBL] [Abstract][Full Text] [Related]
14. Bone Mineral Density in Schizophrenia: An Update of Current Meta-Analysis and Literature Review Under Guideline of PRISMA.
Tseng PT; Chen YW; Yeh PY; Tu KY; Cheng YS; Wu CK
Medicine (Baltimore); 2015 Nov; 94(47):e1967. PubMed ID: 26632691
[TBL] [Abstract][Full Text] [Related]
15. Osteoporosis and fracture risk in people with schizophrenia.
Kishimoto T; De Hert M; Carlson HE; Manu P; Correll CU
Curr Opin Psychiatry; 2012 Sep; 25(5):415-29. PubMed ID: 22744405
[TBL] [Abstract][Full Text] [Related]
16. Reduced bone mineral density in patients with schizophrenia receiving prolactin raising anti-psychotic medication.
Meaney AM; O'Keane V
J Psychopharmacol; 2003 Dec; 17(4):455-8. PubMed ID: 14870961
[TBL] [Abstract][Full Text] [Related]
17. Decreased bone mineral density in medicated psychiatric patients.
Halbreich U; Rojansky N; Palter S; Hreshchyshyn M; Kreeger J; Bakhai Y; Rosan R
Psychosom Med; 1995; 57(5):485-91. PubMed ID: 8552740
[TBL] [Abstract][Full Text] [Related]
18. A review of the effect of anticonvulsant medications on bone mineral density and fracture risk.
Lee RH; Lyles KW; Colón-Emeric C
Am J Geriatr Pharmacother; 2010 Feb; 8(1):34-46. PubMed ID: 20226391
[TBL] [Abstract][Full Text] [Related]
19. Schizophrenia and osteoporosis.
Lean M; De Smedt G
Int Clin Psychopharmacol; 2004 Jan; 19(1):31-5. PubMed ID: 15101568
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
O'Keane V
J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
